Yihua Shi

Shanghai Cancer Institute

Papers

1

Total Citations

10

H-Index

1

About

Yihua Shi is a pioneering hepatobiliary and pancreatic surgeon whose research centers on minimally invasive surgical techniques for complex pancreatic tumors. Dr. Shi’s most impactful contribution challenges a long-held surgical dogma: that tumors involving the main pancreatic duct (MPD) are contraindicated for enucleation. In a landmark 2023 study, Shi demonstrated that laparoscopic and robotic enucleation can be safely performed even for MPD-adjacent lesions, effectively “opening a restricted area” in pancreatic surgery. This work, already garnering 10 citations, has reshaped clinical decision-making, offering patients a parenchyma-sparing alternative to radical resection. By analyzing consecutive cases from Fudan University Shanghai Cancer Center, Shi provided robust evidence that minimally invasive enucleation yields favorable outcomes without compromising oncologic safety. The study’s impact extends beyond its citation count, influencing surgical guidelines and inspiring further research into organ-preserving approaches. Dr. Shi’s dedication to advancing surgical frontiers—combining technical innovation with rigorous clinical validation—positions them as a rising leader in pancreatic surgery, with potential to reduce morbidity for countless patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Shanghai Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago